SCHEMBL30308223

SCHEMBL30308223

Cc1cccc(-c2ccn(-c3cc(N4CCOCC4)nc(O)n3)n2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 9/20 0.47
PIK3CB P42338 4/20 0.46
PIK3CD O00329 3/20 0.46
PIK3CG P48736 2/20 0.46
SMN1; SMN2 Q16637 1/20 0.45
HTT P42858 1/20 0.44
MAPT P10636 3/20 0.44
HSD17B10 Q99714 3/20 0.44
KDM4E B2RXH2 3/20 0.44
TSHR P16473 2/20 0.44
HPGD P15428 2/20 0.44
NPC1 O15118 1/20 0.44
ALDH1A1 P00352 1/20 0.44
CASP3 P42574 1/20 0.44
RAB9A P51151 1/20 0.44
KMT2A Q03164 1/20 0.44
SENP8 Q96LD8 1/20 0.44
SENP7 Q9BQF6 1/20 0.44
SENP6 Q9GZR1 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23755181 1.00 PIK3CA (0.47) PIK3CAPIK3CBPIK3CDPIK3CGSMN1; SMN2
SCHEMBL23755418 0.91 PIK3CA (0.47) PIK3CAPIK3CBPIK3CDPIK3CGSMN1; SMN2
SCHEMBL23773622 0.90 PIK3CA (0.43) PIK3CAPIK3CBPIK3CDPIK3CGSMN1; SMN2
SCHEMBL30087489 0.89 PIK3CA (0.46) PIK3CAPIK3CBPIK3CDPIK3CGSMN1; SMN2
SCHEMBL30087415 0.89 PIK3CA (0.46) PIK3CAPIK3CBPIK3CDPIK3CGSMN1; SMN2
SCHEMBL23754964 0.89 PIK3CA (0.46) PIK3CAPIK3CBPIK3CDPIK3CGSMN1; SMN2
SCHEMBL23755420 0.89 PIK3CA (0.46) PIK3CAPIK3CBPIK3CDPIK3CGSMN1; SMN2
SCHEMBL23755443 0.89 CRHBP (0.50) PIK3CAPIK3CBPIK3CDPIK3CGSMN1; SMN2
SCHEMBL23755212 0.89 PIK3CA (0.46) PIK3CAPIK3CBPIK3CDPIK3CGSMN1; SMN2
SCHEMBL23986112 0.89 CNR2 (0.44) PIK3CAPIK3CBPIK3CDPIK3CGSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230135152-A1 PIKFYVE KINASE INHIBITORS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2023-05-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230135152-A1 PIKFYVE KINASE INHIBITORS PIKFYVE, PIP5K1B, PIP5K1C PIK3CA 9/4885PIK3CB 7/4885PIK3CD 12/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.